HKG Equity Snapshot
6855 Weekly Equity Report
Ascentage Pharma Group International
What the company does
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for …
What the weekly tape is saying
6855 closed the latest completed week at 34.90 HKD. The 4-week return is -11.2% and the 12-week return is -18.2%. Trend Signal is inactive, Market Dynamics is -0.23. Setup signature: Risk-first tape with a 18/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 48.68 HKD
- Vs Trend Line
- -28.3%
- Fair Value
- 40.68 HKD
- Vs Fair Value
- -14.2%
- 52W High
- 95.35 HKD
- 52W Low
- 32.50 HKD
- Drawdown
- -63.4%
- Range Position
- 3.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 20
- 52W Active Breadth
- 38.5%
- Sector Scope
- HK Healthcare
- Sector Rank
- 87 of 257
- Sector Percentile
- 66.4%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- 43 of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 20 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.23
- 4W MD Change
- -210.8%
- Relative Strength
- -39.87
- 4W RS Change
- -7.2%
- Expectation
- Undecided
- Probability
- 47.46%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 13.9M
- 13W Average
- 12.1M
- 52W Average
- 14.5M
- Vs 13W
- 1.2x
- Vs 52W
- 1.0x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 7.6%
- 52W Volatility
- 6.7%
- Upside Weeks
- 18
- Downside Weeks
- 34
- Downside Breadth
- 65.4%
- Avg Gain / Loss
- 7.0% / -5.1%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 14.0B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 34.90 HKD | 0.2% | 48.68 HKD | 40.68 HKD | -0.23 | -39.87 | 13.9M | Off |
| 5 Jun 2026 | 34.82 HKD | -11.3% | 49.77 HKD | 40.60 HKD | -0.09 | -41.17 | 15.4M | Off |
| 29 May 2026 | 39.24 HKD | -5.8% | 50.69 HKD | 40.51 HKD | 0.01 | -34.78 | 11.5M | Off |
| 22 May 2026 | 41.64 HKD | 6.0% | 51.60 HKD | 40.39 HKD | 0.08 | -32.26 | 13.2M | Off |
| 15 May 2026 | 39.30 HKD | -7.8% | 52.48 HKD | 40.26 HKD | 0.21 | -37.20 | 14.2M | Off |
| 8 May 2026 | 42.64 HKD | -4.5% | 53.44 HKD | 40.13 HKD | 0.46 | -33.20 | 9.9M | Off |
| 1 May 2026 | 44.66 HKD | -4.6% | 54.43 HKD | 39.99 HKD | 0.53 | -28.62 | 6.4M | Off |
| 24 Apr 2026 | 46.80 HKD | -11.3% | 55.50 HKD | 39.84 HKD | 0.78 | -26.03 | 14.1M | Off |
| 17 Apr 2026 | 52.75 HKD | 7.3% | 56.37 HKD | 39.69 HKD | 0.64 | -17.56 | 12.9M | Off |
| 10 Apr 2026 | 49.14 HKD | -5.6% | 57.12 HKD | 39.50 HKD | 0.07 | -22.24 | 7.5M | Off |
| 3 Apr 2026 | 52.05 HKD | 13.3% | 58.12 HKD | 39.36 HKD | -0.33 | -15.00 | 14.6M | Off |
| 27 Mar 2026 | 45.96 HKD | 7.7% | 59.03 HKD | 39.17 HKD | -0.89 | -24.40 | 13.7M | Off |
| 20 Mar 2026 | 42.68 HKD | -6.3% | 60.27 HKD | 39.02 HKD | -1.23 | -30.69 | 9.5M | Off |
| 13 Mar 2026 | 45.54 HKD | 0.6% | 61.87 HKD | 38.91 HKD | -1.30 | -26.52 | 10.7M | Off |